Introduction
Following anterior cruciate ligament ͑ACL͒ reconstruction, clinically important increases in anterior knee laxity ͑Ͼ3 mm ͓1͔͒ occur in 9-22% of knees during the first 2 years ͓2,3͔. One possible cause of an increase in anterior laxity is lengthening of the graft construct, particularly lengthening at the sites of fixation ͓4,5͔.
A millimeter-for-millimeter relation between an increase in length of the graft construct and an increase in anterior laxity has been demonstrated in vitro ͓6-8͔. Based on this relation, if there is a 3 mm increase in length of the graft construct following surgery, then a 3 mm increase in anterior laxity or a clinically unstable knee might be expected. A previous in vivo study demonstrated that the millimeter-for-millimeter relation existed for a soft-tissue autograft fixed with an interference screw fixation ͓9͔, which has been demonstrated in vitro to be slippage-prone for soft-tissue grafts ͓10-13͔, but was not valid for a bone-patellar tendon-bone autograft fixed with an interference screw ͓9͔. Therefore, the relation between lengthening of the graft construct and an increase in anterior laxity in vivo appears to be graft construct dependent.
Because the relation between lengthening of the graft construct and an increase in anterior laxity appears to be graft construct dependent in vivo, it would be beneficial to determine whether this relation exists for slippage-resistant fixation of tibialis allografts, which are recently becoming popular due to their availability, large cross-sectional areas, increased stiffness and strength compared with bone-patellar tendon-bone grafts, ability to mimic the anatomy of the original ACL ͑i.e., two functional bundles͒, reduced surgical time, lack of donor site morbidity, and similar clinical outcomes as autografts ͓2,3,14,15͔. If the relation does not exist, then it would be of interest to determine to what extent the increase in stiffness caused by biologic healing of the graft to the bone tunnel ͓16͔ offsets the potential increase in anterior laxity resulting from lengthening at the sites of fixation. Therefore, the primary objectives were to determine whether the millimeter-formillimeter relation exists in vivo for slippage-resistant fixation of a soft-tissue graft and, if it does not exist, then to what extent the increase in stiffness caused by biological healing of the graft to the bone tunnel offsets the potential increase in anterior laxity resulting from lengthening at the sites of fixation.
Roentgen stereophotogrammetric analysis ͑RSA͒ has been used to measure lengthening at the sites of fixation and the increase in anterior laxity in vivo ͓9,17͔. Because systematic and random errors will affect the measurement of lengthening at the sites of fixation and the increase in anterior laxity, it is important to quantify these errors for the specific application of the measurement system. The bias ͑systematic͒ and precision ͑random͒ errors when using RSA to measure the distance between two markers have been determined to be 0.0 and 0.05 mm, respectively ͓18͔. A factor that can inflate this error in measuring lengthening at the sites of fixation is migration of markers injected into soft-tissue grafts. A previous in vitro study determined that migration of markers injected into soft-tissue grafts does not occur ͓19͔. However, in vivo it is possible that migration of injected markers could occur due to the biologic healing of the graft to the bone tunnel, remodeling of the graft substance, and nonaxial loading. Also, the precision of RSA to measure the increase in anterior laxity has been determined in vitro ͑0.33 mm͒ ͓20͔; however, this precision may not be valid in vivo because of muscle activation. Therefore, the secondary objectives were to evaluate the precision of the measurement of anterior laxity in vivo and to determine whether migration of the implanted markers affects the measurement of lengthening at the sites of fixation.
Materials and Methods
All subjects with an ACL tear either chronic or acute, who were referred to the office of Barad and Howell, Sacramento, CA, between June 2007 and September 2008, and who were considering treatment with a tibialis tendon allograft, were considered for participation in this study. Chronic was defined as the date of the injury preceding the date of the surgery by more than 3 months. The inclusion criteria were: a torn ACL, intact posterior cruciate ligament ͑PCL͒, full motion at the time of reconstruction, no roentgenographic evidence of degenerative arthritis, no ligament injuries to either the medial or lateral collateral ligament, no previous ACL reconstruction procedures, and a willingness to participate in the study and be evaluated for up to 1 year postoperatively. Subjects were excluded from the study if they did not meet all of the inclusion criteria. Subjects who agreed to participate were given written information about the risks and benefits of allograft treatment. Twenty-three subjects were enrolled in the study and signed written consent forms approved by our institutional review boards ͑the ethical review board of Catholic Healthcare West and the IRB of UC Davis͒.
The arthroscopically assisted ACL reconstruction with a 9-mm in diameter, fresh-frozen nonirradiated, nonchemically treated tibialis allograft ͑Musculoskeletal Transplant Foundation, Edison, NJ͒ was performed under general anesthesia with use of a previously described technique ͓21͔. Briefly, the tibial and femoral drill holes were made using a transtibial technique to avoid roof impingement, PCL impingement, and to match the tension pattern of the intact ACL during passive motion. Avoiding roof and PCL impingement and matching the tension pattern of the intact ACL is necessary to prevent lengthening of the graft from mechanical causes ͓22,23͔.
To provide references for computing the increase in anterior laxity and lengthening at the sites of fixation using RSA, a previously described technique was used to inject tantalum markers into the femur, tibia, and tibialis allograft during the surgical procedure and press-fit markers into the fixation devices prior to the surgical procedure ͓8͔. Briefly, tantalum markers 0.8-mm in diameter ͑model 20401, Tilly Medical Products AB, Lund, Sweden͒ were implanted in the femur ͑N=6͒ and tibia ͑N=6͒ near the joint line and widely dispersed with use of a bead injector ͑model 20202, Tilly Medical͒ ͑Fig. 1͒. Tantalum markers 0.8-mm in diameter were injected into one strand ͑N=4͒ and tantalum markers 1.0-mm in diameter were injected into the other strand ͑N=4͒ of the tibialis allograft. The markers were positioned in the strands so that they were confined within the bone tunnels. Tantalum markers 1.0-mm in diameter were press-fit into holes milled into a slippage-resistant femoral fixation device ͑N=3͒ ͑9-10 mm standard EZLoc, Biomet Sports Medicine, Inc., Warsaw, IN͒ and a multispiked, slippage-resistant tibial fixation device ͑N=3͒ ͑size 18 WasherLoc, Biomet Sports Medicine, Inc.͒ ͑Fig. 2͒.
After inserting the markers, the tibialis allograft was fixed to the femur, tension was manually applied to the distal end of the graft, and the knee was flexed and extended for 15 cycles to assure proper femoral fixation and seat the graft in the fixation , tibia "T1-T6…, graft "G1-G8…, femoral fixation device "EL1-EL3…, and tibial fixation device "WL1-WL3…. Markers with a diameter of 1.0 mm were injected into one strand "G1-G4… and markers with a diameter of 0.8 mm were injected into the other strand "G5-G8…. All the markers in the allograft were inside the bone tunnels with markers G1, G4, G5, and G8 inserted 5 mm from the fixation device, and markers G2, G3, G6, and G7 inserted 5 mm inside the tunnel. The different diameters allowed the markers in each strand to be identified unambiguously. Fig. 2 The locations of the 1.0-mm in diameter tantalum markers "arrows… are shown in the multispiked tibial fixation device "left… and the femoral fixation device "right…. Three markers were press-fit into milled holes made with a 0.94-mm diameter ball end mill.
device and the fixation device in bone. With the knee in maximum extension and the heel resting on a Mayo stand, a large, unmeasured, tensile force was manually applied to the distal end of the graft and the multiple-spike tibial fixation device was inserted and compressed with a cortical screw. Fixation was completed by inserting a 25-mm long, 8-mm in diameter autogenous bone dowel previously harvested from the tibial tunnel alongside the tibialis allograft, which increases stiffness and promotes circumferential tendon tunnel healing ͓16,24,25͔. The wound was closed, 30 cc of bupivocaine with epinephrine mixed with 30 mg of ketorolac was injected in the knee and incisions, and 30 mg of ketorolac was administered intravenously. Compression and cold therapy were applied with a cuff ͑Knee Cryo Cuff, Aircast, Vista, CA͒.
Within 2 hours following surgery, the leg was inserted into a loading apparatus, which consisted of a calibration cage, ankle and thigh supports that restrained the movement of the leg under load, a pneumatic actuator that applied posterior and anterior forces to the shank, two load cells: one at the ankle support and one at the pneumatic actuator, and two portable X-ray machines ͑model HF80H+, MinXray Inc., Northbrook, IL͒ ͑Fig. 3͒ ͓8͔. The knee was centered in a calibration cage ͑model 10, Tilly Medical Products͒ and a goniometer was used to position the knee in 25 deg of flexion. The ankle and thigh supports were secured. The pneumatic actuator was secured about the proximal tibia 12.5 cm distal to the joint line of the knee. The portable X-ray machines were positioned to expose anterior/posterior and lateral views of the knee ͑i.e., biplanar͒ at a distance of 87 cm from their respective film plane. Measurements were obtained so that the setup of the limb, load apparatus, and X-ray machines could be reestablished when testing the knee at each follow-up visit.
Surface electromyography was used to monitor muscle activation and the biplanar radiographs were taken when there was no muscle activation present. Surface electrodes ͑Bagnoli-8, DelSys, Boston, MA͒ were positioned over the vastus lateralis, long head of the biceps femoris, and medial head of the gastrocnemius muscles because contraction of each of these muscles affects anterior laxity ͓26-29͔. To detect muscle activation, we relied on a previous study, which determined the optimal electromyogram ͑EMG͒ processing parameters necessary to detect activation ͓30͔. The processing parameters used resulted in zero error in detecting the onset of activation. The onset of muscle activation turned on a light, which provided visual feedback to both the examiner and subject.
Biplanar radiographs of the knee were obtained to define an anatomical coordinate system at the center of rotation of the knee ͓8,20͔. A line connecting three tantalum markers that were fixed in the housing of the pneumatic actuator defined the anterior direction ͑+x-axis͒ of the anatomical coordinate system. The cross product of the x-axis and the line passing through the centers of the femoral condyles defined the distal direction ͑+z-axis͒ and the cross product of the z-axis and x-axis defined the lateral direction ͑+y-axis͒ of the anatomical coordinate system ͓8͔.
Anterior and posterior forces were applied to the tibia and biplanar radiographs were obtained to determine the initial anterior position of the tibia with respect to the femur and the reference position of each marker for the subsequent computations of lengthening at the sites of fixation. The knee was not preconditioned because preconditioning might have caused lengthening at the sites of fixation causing an underestimation of the subsequent computation of lengthening at the sites of fixation. Using a previously described technique, standardized forces of 90-N posterior and 150-N anterior were transmitted at the knee ͓20͔. After transmitting the 90-N posterior force at the knee, the 150-N anterior force was transmitted at the knee and biplanar radiographs were obtained when the muscle activation light was unlit.
Following testing on the day of surgery, the subject was instructed to weight-bear as tolerated without a brace, begin flexion and extension exercises, and was discharged from the hospital. Rehabilitation was self-administered with the goal of walking without crutches by 1 to 2 weeks, jogging by 8 weeks, and return to sport by 4 months ͓31,32͔.
Follow-up tests were performed at 1 month ͑29Ϯ 3 days͒, 2 months ͑60Ϯ 4 days͒, 3 months ͑94Ϯ 4 days͒, and 4 months ͑124Ϯ 8 days͒ ͑meanϮ standard deviation͒. The position of the limb was reestablished in the loading apparatus. The knee was preconditioned by applying ten cycles at 1/4 Hertz of a 90-N posterior force followed by a 150-N anterior force transmitted at the knee. Biplanar radiographs were exposed with a 150-N anterior force transmitted at the knee.
RSA was used to determine the three-dimensional positions of the markers. Analysis of the radiographs was performed using a customized RSA data analysis system described previously ͓18͔. Briefly, each radiograph was scanned ͑Epson 1600, Epson America Inc., Long Beach, CA͒ to provide a 300 dpi digital image ͑Fig. 4͒. The two-dimensional coordinates defining the centroid of each marker were measured with use of image analysis software "F1-F6…, tibia "T1-T6…, graft "G1-G8…, femoral fixation device "EL1-EL3…, and tibial fixation device "WL1-WL3… are indicated. The tantalum markers fixed to the fixation devices can be distinguished because the devices are made from less radioopaque metals.
͑Scion Image 1.0, Scion Corporation, Frederick, MD͒. A customized software program was written with use of commercial software ͑MATLAB version 6.0, The Mathworks Inc., Natick, MA͒ to determine the position of the tibia with respect to the femur along the x-axis and lengthening at each site of fixation. The bias and random error of this RSA system are 0.0 and 0.05 mm, respectively ͓18͔.
Lengthening at the sites of fixation was determined as the change in position of the fixation devices and of the markers in the graft along the direction of the tunnels. A previously described methodology was used that defines the directions of the tunnels from the markers in the graft, computes both the 3D position of the markers in each fixation device with respect to the bone, and the position of the markers in the graft within the tunnels with respect to the fixation devices ͓8,33͔. The change in the position over time defines lengthening between the fixation devices and their respective bone and the lengthening between the graft and each fixation device. The lengthening at each site of fixation ͑i.e., tibia and femur͒ was the sum of the lengthening between the fixation device and bone and between the graft and the fixation device. Total lengthening at the sites of fixation was the sum of the lengthening at both sites of fixation.
The increase in anterior laxity was determined by computing the difference in the position of the tibia with respect to the femur between each follow-up test and the position found on the day of surgery along the x-axis of the anatomical coordinate system under application of the 150-N anterior force transmitted at the knee.
To determine whether the millimeter-for-millimeter relation exists, a simple linear regression on the pooled subject data was used. The dependent variable was the increase in anterior laxity and the independent variable was total lengthening at the sites of fixation. This was performed for the month when the average total lengthening at the sites of fixation had the greatest incremental increase as this increase was expected to translate into an increase in anterior laxity based on the millimeter-for-millimeter relation.
To determine the extent to which an increase in stiffness from biological healing of the graft to the bone tunnel offset the potential increase in laxity resulting from lengthening at the sites of fixation, the graft construct was modeled using three springs in series ͑Fig. 5͒ ͓13͔. The three springs represented the stiffness of the site of femoral fixation ͑K f ͒, the stiffness of the graft ͑K g ͒, and the stiffness of the site of tibial fixation ͑K t ͒. On the day of surgery, the initial graft construct stiffness was represented by
where K gc0 was the overall initial graft construct stiffness. Known values for the stiffness of the graft ͑400 N/mm͒ ͓34͔ and tibial fixation ͑565 N/mm͒ ͓24͔ were used, while the stiffness of the femoral fixation was estimated to be 200 N/mm. These values yielded a stiffness of the graft construct ͑K gc0 ͒ of 108 N/mm. On the day of surgery, the predicted contribution of the springs-inseries model to anterior laxity ͑␦ 0 ͒ was computed from ␦ 0 = F / K gc0 where F was the force transmitted at the joint line or 150 N ͑assuming the majority of the force transmitted at the joint line is transmitted to the ACL͒ ͓35,36͔, making ␦ 0 = 1.4 mm.
The increase in stiffness from biologic healing of the graft to the bone tunnel and from shortening of the graft also was determined using values of the individual springs in the model. At 1 month after surgery when biologic healing of the graft to the bone tunnel has occurred to a large extent ͓16,37,38͔, stiffness of all components of the graft construct increased. Therefore, the tibial and femoral fixation stiffness values were increased to 1194 and 304 N/mm, respectively, at 1 month based on previous studies, which have demonstrated a 136% increase ͓16͔ and 52% increase ͓39͔ in stiffness at the sites of tibial and similar cross-pin femoral fixation during the first month, respectively. Healing of the graft to the tunnel wall also increased the stiffness of the graft to 1200 N/mm by effectively shortening the graft from 95 mm to 30 mm assuming the graft was healed solidly at the aperture of the bone tunnel entrance into the intra-articular space. Thus, the computed stiffness of the graft construct ͑K gc1 ͒ at 1 month nearly doubled to 205 N/mm and the contribution to anterior laxity ͑␦ 1 ͒ was 0.7 mm. The increase in anterior laxity ͑⌬AL͒ predicted by the springs-in-series model due to the graft construct stiffness in conjunction with lengthening at the sites of fixation ͑L SF ͒ can be determined from
͑2͒
To determine the precision of the anterior laxity measurement, three sets of biplanar radiographs were obtained in 12 randomly selected subjects 1 month post-operatively. Each set of biplanar radiographs was obtained after removing the knee from the loading apparatus, reestablishing its position, preconditioning for ten cycles, and applying a 150-N anterior force transmitted at the knee. The variance in the measurement of the position of the tibia with respect to the femur from the three sets of radiographs was determined for each subject. The precision of the anterior laxity measurement was the square root of the pooled variance of these 12 subjects.
To determine whether migration of the implanted markers used to measure lengthening at the sites of fixation affects the measurement of lengthening at the sites of fixation, a correlation analysis was performed. The change in position of each of the eight markers injected into the graft with respect to the bone ͑i.e., distance of the marker from the bone-fixed coordinate system origin͒ was computed. The change in length of the vector between each marker pair ͑i.e., near the fixation and near the joint line͒ in each strand in each tunnel along the axis of the respective tunnel was also determined. Pearson's correlation coefficients between the change in length of the vector between marker pairs and the change in position of the markers with respect to bone were computed to assess whether migration occurred systematically for the markers either near the joint line or near the fixations.
Results
Seven of twenty-three subjects that consented to participate in the study were subsequently excluded for several technical reasons. Two subjects were excluded intraoperatively because of a mechanical problem with the bead injector that prevented installation of the markers. Two subjects were excluded during testing on the day of surgery, one because he/she could not tolerate the application of force due to knee pain, and one because of an equipment malfunction that prevented an accurate measurement of anterior laxity. In three subjects, the markers were not injected into the graft properly and lengthening at the sites of fixation could not be computed. Therefore, data was collected from 16 subjects, 13 males and three females with a mean age of 36Ϯ 10 years ͑range, 18-47͒. Of these 16 subjects, five had acute tears ͑less than 3 months͒, ten had chronic tears, and one subject could not be classified.
Lengthening at the sites of fixation did not correlate with increases in anterior laxity 1 month after surgery ͑R 2 = 0.0, slope = 0.2͒. The average lengthening at the sites of fixation had its The stiffness of the graft construct "K gc … is determined from
greatest increase of 1.5Ϯ 0.8 mm ͑averageϮ standard deviation͒ at 1 month and the average increase in anterior laxity was 0.6Ϯ 1.8 mm ͑Table 1, Fig. 6͒ .
The change in the anterior laxity predicted from Eq. ͑2͒ after 1 month was ⌬AL= 0.8 mm. Hence the increase in stiffness of the graft construct after biologic healing of the graft to the bone tunnel offset the potential increase in anterior laxity that would have occurred with no biologic healing of the graft to the bone tunnel ͑i.e., L SF , which was 1.5 mm͒ by 0.7 mm.
The precision of the anterior laxity measurement was 0.5 mm. Migration of the implanted markers did not affect the measurement of lengthening at the sites of fixation as demonstrated by the correlation coefficients between the change in length of the vector between marker pairs and the change in position of the markers with respect to bone which were not consistently higher for markers near the joint line compared with markers near the fixation ͑Table 2͒.
Discussion
For soft-tissue grafts fixed with slippage-prone fixations, anterior laxity has been shown to increase greater than 3 mm, which is the threshold for a clinically unstable knee, and this increase was due to lengthening at the sites of fixations ͓9͔. Accordingly, for soft-tissue grafts fixed with slippage-resistant fixations, we wanted to determine whether the millimeter-for-millimeter relation exists, and to what extent an increase in stiffness from biologic healing of the graft to the bone tunnel offsets the potential increase in laxity resulting from lengthening at the sites of fixation. There was no correlation between lengthening at the sites of fixation and the increase in anterior laxity ͑R 2 = 0.0, slope= 0.2͒. The stiffness increase in the graft construct from biologic healing offset half of the potential increase in anterior laxity resulting from lengthening at the sites of fixation. The precision of the anterior laxity mea- Fig. 6 Graph showing the average total lengthening at the sites of femoral and tibial fixations together with the average increase in anterior laxity over the 4-month time period of the study. At 1 month, there was no one-to-one correspondence between the total lengthening at the sites of fixation and the increase in anterior laxity. After 1 month, the total lengthening did not increase appreciably, which is a consequence of biologic healing of the graft in the bone tunnels, whereas the increase in anterior laxity continued to increase until 3 months presumably as a result of a decrease in the stiffness of the graft due to remodeling. Table 2 Summary of Pearson's correlation coefficients between the change in length of the vector between marker pairs injected into the tendon and the change in position of the markers with respect to the bone. The correlation analysis demonstrates that correlation coefficients for the markers at one location "near the joint line… were not consistently higher than those at the other location "near the fixation…. surement was high ͑0.5 mm͒ and migration of the markers implanted into the graft did not systematically affect the measurement of lengthening at the sites of fixation. Prior to discussing these results, two methods issues and a few limitations need to be addressed. One methods issue that might affect the results of the study is the timing of the initial measurement of anterior laxity. The initial position of the tibia, with respect to the femur under application of the 150-N anterior force, was taken within hours following surgery when there was a bandage applied to the knee, 30 cc of bupivocaine with epinephrine mixed with 30 mg of ketorolac was injected into the capsule, and the knee was effused. Because the increase in anterior laxity is computed from the initial position of the tibia with respect to the femur under application of the 150-N anterior force, it is possible that the millimeter-for-millimeter relation could be affected. The combined effects of the bandage, the injected ketorolac, and the effusion of the knee following surgery might be expected to cause an increase in stiffness of the joint and an underestimation of the initial position of the tibia with respect to the femur. This underestimation of the initial position would cause an overestimation of the increase in anterior laxity. Because the millimeter-for-millimeter relation was not demonstrated due to larger values of lengthening at the sites of fixation ͑1.5Ϯ 0.8 mm averageϮ standard deviation͒ than the smaller increases in anterior laxity ͑0.6Ϯ 1.8 mm͒, and it is possible that the increase in anterior laxity was overestimated, this methods issue does not affect the lack of correlation between lengthening at the sites of fixation and the increase in anterior laxity.
A second methods issue that might affect results is the time of the load application. Time dependent response in the form of creep should not have affected the results because the time of loading was relatively short ͑approximately 10 s͒ so that significant creep did not have time to develop ͓34͔.
The method used to apply the initial tension also might have affected our results. Initial tension to the graft was applied manually, was unmeasured, and was not reacted by the tibia. This method was chosen because it is commonly used clinically and results in a clinically stable knee as demonstrated by our results ͑Fig. 6͒ and those of others ͓40͔ when used in conjunction with the other independent variables of our surgical technique which define the graft construct ͑i.e., graft type, tunnel placement, and fixation methods͒.
One limitation of the present study is that the springs-in-series model was not useful for estimating the total ͑as opposed to a change in͒ anterior-posterior laxity for two reasons. One reason is that this model cannot account for the posterior reference position, which was defined by the posterior force transmitted by the knee. A posterior reference position defined under an applied posterior force reduced variability of anterior-posterior laxity measurements when determined with a zero-load posterior reference position ͓41-44͔. A second reason is that the knee has both high and lowstiffness regions ͓45͔ so that the anterior laxity measured under the 150-N anterior force applied in our study results from the sum of two contributions, one in each region. Because the springs-inseries model applies to the high-stiffness region and because the majority of the laxity is due to the contribution from the lowstiffness region, the model is inherently limited in estimating the total laxity. However, our interest was in the increase in anterior laxity from the day of surgery to 1 month post-surgery. Because the knee was in the high-stiffness region due to the magnitude of load applied, the model was useful for estimating the decrease in anterior laxity that occurred solely due to a change in stiffness.
A second possible limitation of the springs-in-series model is that it can only account for a change in stiffness due to biologic healing of the graft to the bone tunnel, whereas it is also possible that a change in stiffness could result from remodeling of the graft. A previous study demonstrated a 162% decrease in stiffness of allografts during the first 6 weeks following ACL reconstruction in a goat model ͓46͔. This decrease in stiffness increases ⌬AL by 0.2 mm, which corresponds to a decrease in the offset of lengthening at the sites of fixation on anterior laxity from 0.7 mm to 0.5 mm, which is small.
A final limitation of the springs-in-series model is that the stiffness of the femoral fixation had to be estimated at time zero because it has not been previously measured. To apply the springsin-series model for our purposes, the stiffness of each of the three components was necessary. The stiffness at the site of tibial fixation and the stiffness of the graft were measured previously so these values were taken directly from the literature. The stiffness at the site of femoral fixation has not been measured previously and the value used was taken from similar types of fixation devices ͓47,48͔. The largest standard deviation ͑worst case͒ of the measured stiffness of the femoral fixation presented in these previous studies is 68 N/mm. The value ͑200 N/mm͒ Ϯ1 standard deviation ͑132 and 268 N/mm͒ causes ⌬AL to vary from 0.7 to 0.9 mm. This changes the offset of lengthening at the sites of fixation on anterior laxity by Ϯ0.1 mm, which is minimal.
Our result that lengthening at the sites of fixation did not produce a corresponding increase in anterior laxity in vivo ͑R 2 = 0.0͒ is different than the millimeter-for-millimeter relation determined in vitro ͓6-8͔. Because the millimeter-for-millimeter relation did not exist for slippage-resistant fixation of a tibialis allograft and because biologic healing of the graft to the bone tunnel might offset the lengthening at the sites of fixation, a springs-inseries model was used to assess this offset. Our result of a 50% decrease in the increase in anterior laxity from the effects of biologic healing of the graft to the bone tunnel demonstrates that biologic healing of the graft to the bone tunnel appears to offset to a large degree the increase in anterior laxity, resulting in a more stable knee.
Although biologic healing of the graft to the bone tunnel can offset the increase in anterior laxity caused by lengthening at the sites of fixation when the stiffness of the fixations increases, this is not the case when the stiffness decreases as demonstrated in a previous study ͓9͔. In this previous study, lengthening at the sites of fixation was 3 mm and the increase in anterior laxity was 3.3 mm at 6 weeks following ACL reconstruction thus confirming the millimeter-for-millimeter relation determined in in vitro studies ͓6,8,49͔. One reason that might explain the millimeter-formillimeter relation found in the previous study is the disparity in stiffness caused by the apparent lack of biologic healing of the graft to the bone tunnel. An ovine study, which used soft-tissue grafts and interference screw fixation demonstrated that the stiffness at the site of tibial fixation decreased 40% during the first 4 weeks following ACL reconstruction ͓16͔. Therefore, fixation devices that promote biologic healing of the graft to the bone tunnel when used with soft-tissue grafts may be necessary to offset the increase in anterior laxity caused by lengthening at the sites of fixation. Furthermore, the use of slippage-resistant fixations is advantageous to limit the amount of lengthening at the sites of fixation because the amount of lengthening that can be offset is limited.
The precision of the anterior laxity measurement ͑0.5 mm͒ is improved over previous in vivo studies which used RSA. One previous in vivo study demonstrated a precision of 0.8 mm ͓50͔, another 0.9 mm ͓9͔, while another study demonstrated a 1.1 mm precision ͓17͔. The main reason for the precision in our study being improved over those of the previous studies is probably attributed to our choice of a center-of-rotation coordinate system ͓20͔ and the use of electromyography to detect muscle activation. Because our goal was to accurately detect an increase in anterior laxity of 3 mm and because the precision of our system was 0.5 mm, we are confident in our ability to detect clinically important increases in anterior laxity.
Even though a previous in vivo study demonstrated no migration of markers in portions of the graft inside the bone tunnels ͓9͔, and a previous in vitro study demonstrated no migration of markers injected into single-looped grafts ͓19͔, the possibility of marker migration was assessed as any migration effects could bias the measurement of lengthening at the sites of fixation. The assessment was a worthwhile objective because different grafts and fixations were used ͑i.e., distal fixation versus aperture fixation͒ and because different dynamics such as the windshield washer effect ͓51͔ might have caused the markers near the joint line to migrate independently of the markers near the fixations. Indeed, as a result of the latter effect, it was expected that if systematic migration occurred, then it would be restricted to the markers near the joint line. However, the results of the correlation analysis ͑Table 2͒ demonstrated that correlation coefficients for the markers at one location were not consistently higher than those at the other location. Accordingly, migration of markers did not systematically affect the results of our measurement of lengthening at the sites of fixation.
The in vivo findings of the relatively small amount of lengthening at the sites of fixation for slippage-resistant fixations in the present study, and the relatively large amount of lengthening at the sites of fixation for the interference screw with a soft-tissue graft in the previous study ͓9͔ raises a question as to whether the results of in vitro studies, which measure the performance of fixation devices, carry over to the in vivo environment. For the slippageresistant fixations used in our study, in vivo lengthening at the fixations was less than that in previous in vitro studies ͓4,11,13,52͔. One study in particular reported that the femoral fixation device used in our study failed for all specimens using porcine tibia ͓52͔. Given the results of our study, it is clear that their results do not carry over to the in vivo environment because no femoral fixations failed. For slippage-prone fixation devices, lengthening of interference screw fixation of a soft-tissue graft in vivo was greater than that in in vitro studies ͓9,11͔. Therefore, in vitro testing of slippage-prone fixation devices should be interpreted cautiously particularly because the material properties of animal models such as porcine and older human bone do not duplicate those of young human bone ͓53͔.
In conclusion, there was no correlation between increases in lengthening at the sites of fixation and increase in anterior laxity at 1 month for a soft-tissue graft fixed with slippage-resistant fixation in our in vivo study. Further an increase in graft construct stiffness from biologic healing of the graft to the bone tunnel offset to a large degree the potential increase in laxity resulting from lengthening at the sites of fixation. This occurred because lengthening at the sites of fixation was small.
